Pfizer (company)

Pfizer (company)
source
Name	Pfizer Inc.
Type	Public company
Industry	Pharmaceuticals
Founded	1849
Founders	Charles Pfizer; Charles F. Erhart
Headquarters	New York City, New York, United States
Key people	Albert Bourla (Chairman, CEO); Mike McDermott (CFO)
Products	Pharmaceuticals; Vaccines; Consumer healthcare
Revenue	US$ (see Market performance)
Employees	~80,000

Pfizer (company) is a multinational pharmaceutical and biotechnology corporation headquartered in New York City, New York, United States. Founded in 1849 by Charles Pfizer and Charles F. Erhart in Brooklyn, it has grown into a leading developer of prescription medicines, vaccines, and consumer healthcare products with operations across North America, Europe, Asia, and Latin America. Pfizer is known for landmark products and collaborations involving institutions such as BioNTech, The Rockefeller University, University of Oxford, Centers for Disease Control and Prevention, and World Health Organization.

History

Pfizer traces origins to the founding by Charles Pfizer and Charles F. Erhart in 1849 in Brooklyn, with early success producing chemicals and chemistry-based products for industrial clients, alongside connections to Port of New York. Expansion through the 20th century involved acquisitions and mergers with companies like Warner-Lambert, Wyeth, Pharmacia, and Medivation, shaping its presence in markets linked to New Jersey and Connecticut. Pfizer played roles in industrial efforts during World War I and World War II, including partnerships with U.S. Army programs and collaborations with academic centers like Harvard University and Columbia University. Notable product milestones include development of penicillin production processes with firms in Chicago and St. Louis, the discovery and commercialization of sildenafil-derived therapies after links with GlaxoSmithKline era competitors, and the launch of antiviral agents and vaccines following research at Johns Hopkins University and Stanford University. In the 21st century, strategic alliances with BioNTech, licensing deals with AstraZeneca, and collaborations with Gilead Sciences influenced vaccine and antiviral pipelines, intersecting with global events such as the COVID-19 pandemic and public health responses coordinated by Gavi, the Vaccine Alliance.

Corporate structure and governance

Pfizer operates as a publicly traded company listed on the New York Stock Exchange under the ticker symbol PFE and is governed under U.S. corporate law with a board of directors and executive leadership. The board has included individuals with backgrounds at Goldman Sachs, Johnson & Johnson, Merck & Co., General Electric, and IBM, reflecting ties to global finance and healthcare sectors. Corporate governance practices have been reviewed by agencies such as the U.S. Securities and Exchange Commission and involved interactions with institutional investors including Vanguard Group, BlackRock, and State Street Corporation. Executive decisions have been influenced by mergers reviewed by regulators such as the Federal Trade Commission and the European Commission.

Research, development, and products

Pfizer’s R&D portfolio spans small molecules, biologics, oncology, immunology, vaccines, and rare disease therapies developed in labs connected to Cambridge (UK), Cambridge (Massachusetts), San Francisco, and Groton, Connecticut. Major collaborations include joint development with BioNTech for an mRNA vaccine platform, licensing arrangements with AstraZeneca for viral vector work, and research partnerships with academic institutions like University of Pennsylvania, Yale University, and Massachusetts Institute of Technology. Flagship products have included antiviral medications, oncology agents co-developed with firms such as Allergan and Eli Lilly and Company, and vaccines produced in collaboration with Moderna-era research networks and public health agencies like European Medicines Agency and Food and Drug Administration. Pfizer’s clinical trials have been registered with authorities and conducted across trial sites in Brazil, South Africa, United Kingdom, and Germany, with data reviewed by panels including advisory committees convened by the National Institutes of Health.

Manufacturing and supply chain

Manufacturing facilities and supply chains span global sites in Belgium, Ireland, Puerto Rico, Massachusetts, Romania, and China, with logistics coordinated through ports such as Port of Antwerp and air hubs like John F. Kennedy International Airport. Production of biologics and vaccines has required cold-chain distribution partnerships with freight carriers including FedEx, United Parcel Service, and freight forwarders serving programs supported by UNICEF. Raw material sourcing has involved suppliers in India, Italy, and Germany, with quality oversight by regulators such as the European Medicines Agency and national authorities including Health Canada.

Market performance and financials

Pfizer’s financial performance includes revenue streams from innovative medicines, vaccines, and consumer healthcare, reported in filings with the U.S. Securities and Exchange Commission. Institutional investors such as Berkshire Hathaway have monitored company performance alongside analysts at firms like Goldman Sachs, Morgan Stanley, and JP Morgan Chase. Market capitalization and stock movements have been influenced by product approvals from the Food and Drug Administration and acquisition activity involving targets such as Arena Pharmaceuticals and Mylan competitors, with debt arrangements involving banks like Citigroup and Bank of America.

Legal issues and controversies

Pfizer has faced legal and regulatory challenges in multiple jurisdictions, including settlements with the U.S. Department of Justice and patent litigations in courts like the United States District Court for the Southern District of New York and the European Court of Justice. Controversies have involved pricing disputes reviewed by lawmakers in United States Congress, patent litigation with firms such as Teva Pharmaceutical Industries and Mylan, and compliance investigations by authorities like the Office of Inspector General (United States Department of Health and Human Services). Public scrutiny during public health campaigns has engaged groups such as Doctors Without Borders and debates in venues including hearings before the House Committee on Oversight and Accountability.

Corporate social responsibility and philanthropy

Pfizer engages in philanthropic efforts and public health programs through foundations and partnerships with organizations such as Bill & Melinda Gates Foundation, Gavi, the Vaccine Alliance, Clinton Foundation, and academic collaborators at Johns Hopkins Bloomberg School of Public Health. Corporate social responsibility initiatives include donations of medicines coordinated with United Nations agencies and global health NGOs like World Health Organization and Médecins Sans Frontières, and sustainability reporting aligned with frameworks promoted by CDP (organization) and investors such as CalPERS.

Category:Pharmaceutical companies